Connection

COLIN P DINNEY to Carcinoma in Situ

This is a "connection" page, showing publications COLIN P DINNEY has written about Carcinoma in Situ.
Connection Strength

1.635
  1. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021 01; 22(1):107-117.
    View in: PubMed
    Score: 0.587
  2. Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Gu?rin. Urol Oncol. 2013 Nov; 31(8):1635-42.
    View in: PubMed
    Score: 0.325
  3. ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer. World J Urol. 2019 Jan; 37(1):51-60.
    View in: PubMed
    Score: 0.125
  4. Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy. World J Urol. 2019 Jan; 37(1):165-172.
    View in: PubMed
    Score: 0.124
  5. Salvage topical therapy for upper tract urothelial carcinoma. World J Urol. 2018 Dec; 36(12):2027-2034.
    View in: PubMed
    Score: 0.123
  6. ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013 Jan; 63(1):36-44.
    View in: PubMed
    Score: 0.083
  7. Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery. Urol Int. 2011; 87(1):42-8.
    View in: PubMed
    Score: 0.076
  8. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol. 2013 May; 31(4):480-6.
    View in: PubMed
    Score: 0.075
  9. P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. Urology. 2001 May; 57(5):852-9.
    View in: PubMed
    Score: 0.038
  10. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol Rep. 2001 Jan-Feb; 8(1):9-15.
    View in: PubMed
    Score: 0.037
  11. Novel fluorescence in?situ hybridization-based definition of bacille Calmette-Gu?rin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies. BJU Int. 2016 May; 117(5):754-60.
    View in: PubMed
    Score: 0.025
  12. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst. 2008 Oct 01; 100(19):1401-11.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.